Idralfidine

This classification denotes an alpha-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E2U4W02TMR. European Medicines Agency schedules Idralfidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08118MIG. Idralfidine generally arises in the molecular formula C11H14N4O. The term IDRALFIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, no. 6, 1986, list 26.) IDRALFIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule idralfidine under HS 29332990 and SITC 51573. As of Q4 2014, IDRALFIDINE remains the US FDA Preferred Term for this commodity. Idralfidine bears US NLM identifiers UMLS ID C2827191 and NCI Concept Code C83779. SMILES: CC\1=CC(=O)C=C/C1=C\NNC2=NCCN2.CL.